Gulnaz Begum

Gulnaz Begum

Auto-generated profile, based on publicly available information

Gulnaz Begum

Department of Neurology, the Pittsburgh Institute for Neurodegenerative Diseases University of Pittsburgh Pittsburgh Pennsylvania USA

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2021 in Progress in Neurobiology
Verified
Journal Article
Closed access
SSShanshan Song
Shanshan Song
HHHuachen Huang
Huachen Huang
XGXiudong Guan
Xiudong Guan
VFVictoria Fiesler
Victoria Fiesler
MBMohammad Iqbal H. Bhuiyan
Mohammad Iqbal H. Bhuiyan
GBGulnaz Begum
Gulnaz Begum


19 April 2022 in Cell Death & Disease
Verified
Journal Article
Open access
PDF file
RLRuijia Liu
Ruijia Liu
JWJun Wang
Jun Wang
YCYang Chen
Yang Chen
JCJenelle M. Collier
Jenelle M. Collier
OCOkan Capuk
Okan Capuk
GBGulnaz Begum
Gulnaz Begum
Reactive astrocytes (RA) secrete lipocalin-2 (LCN2) glycoprotein that regulates diverse cellular processes including cell death/survival, inflammation, iron delivery and cell differentiation. Elevated levels of LCN2 are considered as a biomarker of brain injury, however, the underlying regulatory mechanisms of its expression and release are not well understood. In this study, we investigated the role of astrocytic Na+/H+ exchanger 1 (NHE1) in regulating reactive astrocyte LCN2 secretion and neurodegeneration after stroke. Astrocyte specific deletion of Nhe1 in Gfap-CreER+/−;Nhe1f/f mice reduced astrogliosis and astrocytic LCN2 and GFAP expression, which was associated with reduced loss of NeuN+ and GRP78+ neurons in stroke brains. In vitro ischemia in astrocyte cultures triggered a significant increase of secreted LCN2 in astrocytic exosomes, which caused neuronal cell death and neurodegeneration. Inhibition of NHE1 activity during in vitro ischemia with its potent inhibitor HOE642 significantly reduced astrocytic LCN2+ exosome secretion. In elucidating the cellular mechanisms, we found that stroke triggered activation of NADPH oxidase (NOX)-NF-κB signaling and ROS-mediated LCN2 expression. Inhibition of astrocytic NHE1 activity attenuated NOX signaling and LCN2-mediated neuronal apoptosis and neurite degeneration. Our findings demonstrate for the first time that RA use NOX signaling to stimulate LCN2 expression and secretion. Blocking astrocytic NHE1 activity is beneficial to reduce LCN2-mediated neurotoxicity after stroke.

1 January 2024 in Aging and disease
Verified
Journal Article
Open access
PDF file
RLRuijia Liu
Ruijia Liu
JCJenelle M. Collier
Jenelle M. Collier
NANana-Hawwa Abdul-Rahman
Nana-Hawwa Abdul-Rahman
OCOkan Capuk
Okan Capuk
ZZZhongling Zhang
Zhongling Zhang
GBGulnaz Begum
Gulnaz Begum
The blood-brain barrier (BBB) plays a critical role in maintaining ion and fluid homeostasis, essential for brain metabolism and neuronal function. Regulation of nutrient, water, and ion transport across the BBB is tightly controlled by specialized ion transporters and channels located within its unique cellular components. These dynamic transport processes not only influence the BBB’s structure but also impact vital signaling mechanisms, essential for its optimal function. Disruption in ion, pH, and fluid balance at the BBB is associated with brain pathology and has been implicated in various neurological conditions, including stroke, epilepsy, trauma, and neurodegenerative diseases such as Alzheimer’s disease (AD). However, knowledge gaps exist regarding the impact of ion transport dysregulation on BBB function in neurodegenerative dementias. Several factors contribute to this gap: the complex nature of these conditions, historical research focus on neuronal mechanisms and technical challenges in studying the ion transport mechanisms in in vivo models and the lack of efficient in vitro BBB dementia models. This review provides an overview of current research on the roles of ion transporters and channels at the BBB and poses specific research questions: 1) How are the expression and activity of key ion transporters altered in AD and vascular dementia (VaD); 2) Do these changes contribute to BBB dysfunction and disease progression; and 3) Can restoring ion transport function mitigate BBB dysfunction and improve clinical outcomes. Addressing these gaps will provide a greater insight into the vascular pathology of neurodegenerative disorders.

14 July 2003 in Bone Marrow Transplantation
Verified
Journal Article
Closed access
STS Tauro
S Tauro
PSP Shankaranarayana
P Shankaranarayana
INI C Nitu-Whalley
I C Nitu-Whalley
NDN Duncan
N Duncan
GBG Begum
G Begum
PMP Mahendra
P Mahendra

5 August 2025 in Glia
Verified
Journal Article
Open access
OCOkan Capuk
Okan Capuk
EBElise Berthold
Elise Berthold
KKKathiravan Kaliyappan
Kathiravan Kaliyappan
MAMansi Avunoori
Mansi Avunoori
RMRajesh Muduganti
Rajesh Muduganti
GBGulnaz Begum
Gulnaz Begum
The electrogenic sodium bicarbonate transporter 1 (NBCe1/ Slc4a4 ), predominantly expressed in astrocytes, is important for brain pH regulation and homeostasis. Increased NBCe1 expression in reactive astrocytes has been associated with neuronal degeneration in ischemic stroke. However, the effects of astrocytic NBCe1 inhibition in stroke remain contradictory, and the underlying mechanisms are unclear. Here, we show that wild‐type (WT) mice exhibited elevated NBCe1 expression in the peri‐lesional regions at 3 days post‐stroke. Astrocytic Nbce1 gene deletion in inducible Gfap‐Cre ERT2+/− ; Nbce1 f/f mice ( Nbce1 iΔAstro ) resulted in a significant reduction in NBCe1 mRNA and protein expression in astrocytes. Compared to WT stroke mice, Nbce1 iΔAstro mice displayed reduced infarct volume, decreased brain swelling, improved cerebral blood flow, and accelerated neurological function recovery in the 1–5‐day acute post‐stroke period. Moreover, Nbce1 iΔAstro stroke mice exhibited decreased blood–brain barrier (BBB) permeability, accompanied by preserved perivascular AQP4 polarization, upregulation of Kir4.1 protein expression, and reduced astrocyte domain volume. Importantly, Nbce1 iΔAstro stroke brains revealed an anti‐inflammatory cytokine profiling signature, marked by increased TIMP‐1 expression. Together, our findings suggest that astrocytic upregulation of pH regulatory protein NBCe1 after stroke contributes to increased BBB permeability, reactive astrogliosis, inflammation, and perivascular AQP4 dysregulation. Targeting astrocytic NBCe1 may represent a promising new therapeutic strategy to mitigate astroglial dysfunction in the post‐stroke brain.